Suprofen

Suprofen
Clinical data

AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	Oral, eye drops
ATC code	M01AE07 (WHO)
Legal status
Legal status	Discontinued
Pharmacokinetic data
Protein binding	20%
Identifiers
IUPAC name (RS)-2-[4-(2-thienylcarbonyl)phenyl]propanoic acid
CAS Number	40828-46-4^Y
PubChem CID	5359
IUPHAR/BPS	7298
DrugBank	DB00870^Y
ChemSpider	5166^N
UNII	988GU2F9PE
KEGG	D00452^Y
ChEBI	CHEBI:9362^N
ChEMBL	CHEMBL956^N
ECHA InfoCard	100.050.071
Chemical and physical data
Formula	C₁₄H₁₂O₃S
Molar mass	260.309 g/mol
3D model (Jmol)	Interactive image
SMILES O=C(c1ccc(cc1)C(C(=O)O)C)c2sccc2
InChI InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)^N Key:MDKGKXOCJGEUJW-UHFFFAOYSA-N^N
^NY (what is this?)

Suprofen is a non-steroidal anti-inflammatory drug (NSAID) developed by Janssen Pharmaceutica that was marketed as 1% eye drops under the trade name Profenal.

Suprofen was originally used as tablet, but oral uses have been discontinued due to renal effects. It was subsequently used exclusively as a topical ophthalmic solution, typically to prevent miosis during and after ophthalmic surgery. This application has been discontinued as well, at least in the US.

...
Wikipedia